These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of newer antipsychotics on extrapyramidal function. Tarsy D; Baldessarini RJ; Tarazi FI CNS Drugs; 2002; 16(1):23-45. PubMed ID: 11772117 [TBL] [Abstract][Full Text] [Related]
3. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations. J Clin Psychiatry; 1998; 59 Suppl 12():23-7. PubMed ID: 9766616 [TBL] [Abstract][Full Text] [Related]
4. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease. Friedman JH; Factor SA Mov Disord; 2000 Mar; 15(2):201-11. PubMed ID: 10752567 [TBL] [Abstract][Full Text] [Related]
5. Will the new antipsychotics bring hope of reducing the risk of developing extrapyramidal syndromes and tardive dyskinesia? Casey DE Int Clin Psychopharmacol; 1997 Feb; 12 Suppl 1():S19-27. PubMed ID: 9179640 [TBL] [Abstract][Full Text] [Related]
6. Treatment of psychosis in Parkinson's disease: safety considerations. Fernandez HH; Trieschmann ME; Friedman JH Drug Saf; 2003; 26(9):643-59. PubMed ID: 12814332 [TBL] [Abstract][Full Text] [Related]
7. Extrapyramidal adverse events associated with atypical antipsychotic treatment of bipolar disorder. Gentile S J Clin Psychopharmacol; 2007 Feb; 27(1):35-45. PubMed ID: 17224710 [TBL] [Abstract][Full Text] [Related]
8. [Atypical antipsychotics in the elderly]. van Melick EJ; Tijdschr Gerontol Geriatr; 2004 Dec; 35(6):240-5. PubMed ID: 15704604 [TBL] [Abstract][Full Text] [Related]
9. Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management. Pierre JM Drug Saf; 2005; 28(3):191-208. PubMed ID: 15733025 [TBL] [Abstract][Full Text] [Related]
10. The relationship of pharmacology to side effects. Casey DE J Clin Psychiatry; 1997; 58 Suppl 10():55-62. PubMed ID: 9265918 [TBL] [Abstract][Full Text] [Related]
11. Tardive dyskinesia in older patients. Jeste DV J Clin Psychiatry; 2000; 61 Suppl 4():27-32. PubMed ID: 10739328 [TBL] [Abstract][Full Text] [Related]
12. Tolerability profile of atypical antipsychotics in children and adolescents. Stigler KA; Potenza MN; McDougle CJ Paediatr Drugs; 2001; 3(12):927-42. PubMed ID: 11772153 [TBL] [Abstract][Full Text] [Related]
13. Tolerability of atypical antipsychotics. Stanniland C; Taylor D Drug Saf; 2000 Mar; 22(3):195-214. PubMed ID: 10738844 [TBL] [Abstract][Full Text] [Related]
14. EPS profiles: the atypical antipsychotics are not all the same. Weiden PJ J Psychiatr Pract; 2007 Jan; 13(1):13-24. PubMed ID: 17242588 [TBL] [Abstract][Full Text] [Related]
18. Typical and atypical antipsychotics--the misleading dichotomy. Results from the Working Group 'Drugs in Psychiatry' (AGATE). Fischer-Barnicol D; Lanquillon S; Haen E; Zofel P; Koch HJ; Dose M; Klein HE; Neuropsychobiology; 2008; 57(1-2):80-7. PubMed ID: 18515977 [TBL] [Abstract][Full Text] [Related]
19. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients. Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253 [TBL] [Abstract][Full Text] [Related]
20. Implications of the CATIE trial on treatment: extrapyramidal symptoms. Casey DE CNS Spectr; 2006 Jul; 11(7 Suppl 7):25-31. PubMed ID: 16816797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]